NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Chilean business magnate Julio Ponce will leave several of his companies, he said in a statement on Thursday, while the firms announced a broader restructuring that seeks to merge units into fewer entities.Read More